Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zaidenstein

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Clinical Biochemistry|June 1, 1996
Erythrocyte Na+, K+ and Ca2+, Mg(2+)-ATPase activities in hypertensives on angiotensin-converting enzyme inhibitorsA Golik, J Weissgarten, S Evans, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|June 5, 1999
Rhabdomyolysis due to bezafibrate in CAPD patients. A role for dihydropyridine drugs?J Weissgarten, R Zaidenstein, S Fishman, et al.
European Journal of Clinical Pharmacology|August 11, 1998
The effect of grapefruit juice on the pharmacokinetics of orally administered verapamilR Zaidenstein, V Dishi, M Gips, et al.
Clinical Pharmacology and Therapeutics|July 1, 1987
Hydrochlorothiazide-amiloride causes excessive urinary zinc excretionA Golik, D Modai, J Weissgarten, et al.
Journal of the American College of Nutrition|February 27, 1998
Effects of captopril and enalapril on zinc metabolism in hypertensive patientsA Golik, R Zaidenstein, V Dishi, et al.
Clinical Cardiology|March 1, 1997
Conservative treatment for Brucella endocarditisN Cohen, A Golik, I Alon, et al.
Therapeutic Drug Monitoring|July 31, 2001
Effect of grapefruit juice on the pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteersR Zaidenstein, S Soback, M Gips, et al.
Clinical Pharmacology and Therapeutics|August 1, 1997
Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failureG Cotter, J Weissgarten, E Metzkor, et al.
Clinical Cardiology|June 30, 2000
Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failureN Cohen, I Alon, D Almoznino-Sarafian, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 16, 2000
Pharmacokinetics of intraperitoneal piperacillin/tazobactam in patients on peritoneal dialysis with and without pseudomonas peritonitisR Zaidenstein, J Weissgarten, V Dishi, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Clinical Biochemistry|June 1, 1996
Erythrocyte Na+, K+ and Ca2+, Mg(2+)-ATPase activities in hypertensives on angiotensin-converting enzyme inhibitorsA Golik, J Weissgarten, S Evans, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|June 5, 1999
Rhabdomyolysis due to bezafibrate in CAPD patients. A role for dihydropyridine drugs?J Weissgarten, R Zaidenstein, S Fishman, et al.
European Journal of Clinical Pharmacology|August 11, 1998
The effect of grapefruit juice on the pharmacokinetics of orally administered verapamilR Zaidenstein, V Dishi, M Gips, et al.
Clinical Pharmacology and Therapeutics|July 1, 1987
Hydrochlorothiazide-amiloride causes excessive urinary zinc excretionA Golik, D Modai, J Weissgarten, et al.
Journal of the American College of Nutrition|February 27, 1998
Effects of captopril and enalapril on zinc metabolism in hypertensive patientsA Golik, R Zaidenstein, V Dishi, et al.
Clinical Cardiology|March 1, 1997
Conservative treatment for Brucella endocarditisN Cohen, A Golik, I Alon, et al.
Therapeutic Drug Monitoring|July 31, 2001
Effect of grapefruit juice on the pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteersR Zaidenstein, S Soback, M Gips, et al.
Clinical Pharmacology and Therapeutics|August 1, 1997
Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failureG Cotter, J Weissgarten, E Metzkor, et al.
Clinical Cardiology|June 30, 2000
Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failureN Cohen, I Alon, D Almoznino-Sarafian, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 16, 2000
Pharmacokinetics of intraperitoneal piperacillin/tazobactam in patients on peritoneal dialysis with and without pseudomonas peritonitisR Zaidenstein, J Weissgarten, V Dishi, et al.
Pageof 4